Hip Replacement Market Size, Share, and Growth Forecast, 2026 - 2033

The global hip replacement market size is likely to be valued at US$8.9 billion in 2026 and is expected to reach US$13.2 billion by 2033, growing at a CAGR of 5.8% during the forecast period from 2026 to 2033, driven by the rising burden of osteoarthritis, population ageing, hip fractures, and advances in joint reconstruction technologies.

The WHO reported in 2023 that approximately 528 million people worldwide were living with osteoarthritis based on 2019 data, with around 73% aged over 55, reinforcing the long-term need for joint replacement among older adults. Demand is also supported by advances in robotic-assisted surgery, implant design, and outpatient care.

Driver - Technological Advancement in Implants and Surgical Techniques

Technological advancement is strengthening the hip replacement market by improving implant durability, anatomical fit, surgical precision, and recovery pathways. Modern cementless implants, highly wear-resistant bearing materials, dual-mobility designs, and improved fixation surfaces are helping surgeons address varied patient anatomies and reduce complications such as instability and loosening.

Robotic-assisted total hip arthroplasty also supports more consistent component positioning and restoration of limb length. A 2026 review reported that robotic systems improve technical accuracy and reproducibility, although longer-term clinical benefits remain under evaluation. These innovations broaden treatment options, improve procedural confidence, and encourage healthcare providers to upgrade orthopedic capabilities sustainably across markets.

Innovation is also extending beyond implants into digital planning and intraoperative guidance. Three-dimensional templating, navigation, robotic assistance, and advanced imaging enable surgeons to evaluate patient anatomy more precisely before and during total hip arthroplasty. A 2026 review found that artificial intelligence can improve implant-size prediction, reduce planning time, and support component positioning and biomechanical restoration.

Restraint - Surgeon Training and Adoption Curves for New Platforms

Surgeon training and adoption curves can restrain the uptake of advanced technologies in hip replacement because robotic platforms, navigation systems, and digital planning tools require specialized skills. Surgeons must learn new workflows while maintaining proficiency in conventional arthroplasty techniques, creating additional training demands and transition periods. A 2025 study on robotic arthroplasty training found that many residents remained uncomfortable independently using robotic systems, despite recognizing their educational value. Inadequate exposure can delay adoption, particularly in lower-volume centers.

Adoption can also be slowed by workflow disruption, limited training infrastructure, and uncertainty about the incremental clinical value of expensive technologies. A 2025 study examining robotic surgery adoption identified training variation, clinician hesitancy, communication issues, and operating-room constraints as important barriers. In hip replacement, surgeons must assess whether technology improves outcomes sufficiently to justify changes in established procedures and learning requirements.

Opportunity - Technological Convergence with Robotics, AI Planning, and Personalized Implants

Technological convergence creates an important opportunity to transform hip replacement from standardized implant selection toward more individualized treatment. Artificial intelligence can analyze imaging and clinical information to support preoperative planning, implant sizing, risk prediction, and postoperative monitoring, while robotic systems can translate digital plans into controlled intraoperative execution.

A 2026 review of total hip arthroplasty described expanding AI applications across planning, surgery, outcome prediction, and monitoring. Combining these capabilities can improve consistency while preserving surgeon control. The opportunity is particularly significant for complex anatomy, revision procedures, and patients requiring precise restoration of biomechanics, where individualized planning can support better surgical decision-making and workflow efficiency.

Personalized implants and data-driven surgical ecosystems could expand the market by linking patient anatomy, implant design, robotic execution, and longitudinal outcome monitoring. Emerging research is exploring generative design, computational modeling, patient-specific geometries, and functionally graded implant structures intended to better match biological and mechanical requirements.

Procedure Insights

Total hip replacement (THR) is expected to account for 68% of revenue in 2026, due to its established role in treating advanced osteoarthritis, severe cartilage deterioration, hip fractures, and other conditions causing substantial joint damage. The procedure replaces the damaged femoral head and acetabular surface, providing comprehensive joint restoration and improving mobility and quality of life. Its strong clinical acceptance, availability of advanced implant designs, and improvements in surgical planning continue to support its widespread adoption across orthopedic centers. For example, the American Academy of Orthopaedic Surgeons identifies total hip replacement as an established treatment for patients with severe degenerative hip disease.

Hip resurfacing is likely to represent the fastest-growing segment, supported by increasing interest in bone-preserving treatment options, particularly among younger and active patients. Unlike conventional hip replacement, the technique preserves more of the femoral bone while resurfacing the damaged joint surfaces. Growing awareness of bone conservation, improvements in implant technology, and better patient-selection practices are supporting its adoption among suitable candidates. For instance, Smith+Nephew’s Birmingham Hip Resurfacing System is an FDA-approved resurfacing system used for appropriately selected patients.

End-user Insights

Hospitals are projected to lead the market, capturing around 70% of the revenue share in 2026, supported by their comprehensive infrastructure for performing complex orthopedic procedures and managing patients requiring specialized medical care. Hospitals provide access to orthopedic surgeons, anesthesiology teams, diagnostic facilities, intensive monitoring, rehabilitation services, and multidisciplinary care, making them particularly suitable for patients with advanced disease or multiple comorbidities. A notable example is the American Joint Replacement Registry, which collects hip and knee replacement data from participating hospitals to support quality improvement and monitor patient outcomes.

Ambulatory surgical centers (ASCs) are likely to be the fastest-growing end-user due to the increasing shift toward outpatient and same-day hip replacement procedures. ASCs offer dedicated surgical environments, streamlined patient pathways, and efficient postoperative management, making them increasingly attractive for appropriately selected patients who do not require prolonged hospitalization. For example, the American Academy of Orthopedic Surgeons includes ASCs within its quality programs for elective total hip replacement.

North America Hip Replacement Market Trends

North America is anticipated to be the leading region, accounting for a market share of 43% in 2026, supported by an aging population, high prevalence of osteoarthritis, advanced orthopedic infrastructure, and growing use of robotic-assisted surgery. Hospitals and ambulatory surgical centers are increasingly adopting digital planning, minimally invasive approaches, and implant technologies designed to improve surgical precision and recovery. Zimmer Biomet strengthened this trend in the U.S. by receiving FDA clearance for its G7 TM Acetabular System for challenging primary and revision hip replacement procedures in February 2026.

U.S. Hip Replacement Market Trends

The U.S. is expected to dominate the regional market, accounting for approximately 80% of the market share in 2026, driven by high procedure volumes and strong demand for advanced implants. Robotic-assisted hip replacement and AI-enabled surgical planning are gaining adoption among orthopedic providers. Zimmer Biomet’s recent G7 TM clearance supports innovation in complex hip replacement procedures. The expansion of ASC-based orthopedic care is also supporting more streamlined treatment pathways.

Canada Hip Replacement Market Trends

Canada is likely to be a significant market for hip replacement, holding approximately 20% of the market share in 2026, supported by its aging population, which increases the need for joint replacement procedures. Public healthcare systems continue to focus on reducing surgical backlogs and improving access to orthopedic care. Hospitals are increasingly emphasizing efficient surgical pathways and postoperative rehabilitation. Growing adoption of modern implants and minimally invasive techniques is supporting market development.

Europe Hip Replacement Market Trends

Europe is likely to be a significant market for hip replacement in 2026, due to population aging, increasing osteoarthritis burden, and established orthopedic healthcare systems. Germany and the U.K. remain important markets owing to their strong hospital infrastructure, specialist orthopedic services, and growing focus on surgical efficiency. Implant manufacturers are also expanding technologies that support personalized procedures, improved fixation, and robotic-assisted surgery.

U.K. Hip Replacement Market Trends

The U.K. is likely to be a significant market for hip replacement, accounting for 15% of the Europe market share in 2026, supported by established NHS orthopedic services and continuing demand for joint replacement. Reducing waiting times for elective procedures remains an important healthcare priority. Hospitals are increasingly focusing on efficient surgical pathways and improved postoperative recovery. Smith+Nephew’s strong presence in hip implants and orthopedic technologies supports the domestic ecosystem.

Germany Hip Replacement Market Trends

Germany is anticipated to dominate the regional market, accounting for around 37% of the Europe market share in 2026. Germany has a well-developed orthopedic care system with extensive access to hip replacement surgery. An aging population and osteoarthritis prevalence continue to support procedure demand. Hospitals are increasingly adopting modern implant systems and technology-assisted surgical techniques. Germany also remains an important European base for orthopedic manufacturers and medical technology companies.

Asia Pacific Hip Replacement Market Trends

The Asia Pacific region is estimated to be the fastest-growing regional market in 2026, driven by aging populations, urbanization, increasing life expectancy, and growing awareness of orthopedic treatments. China and India remain important markets due to their large patient populations and expanding healthcare infrastructure. Hospitals are gradually improving access to advanced implants, computer-assisted procedures, and minimally invasive surgical techniques. In April 2026, Stryker launched its Trident II Acetabular System in India, offering an advanced implant option for total hip arthroplasty and highlighting continued investment in the region.

China Hip Replacement Market Trends

China is projected to dominate the regional market, holding around 30% share of the market in 2026, due to rising demand for hip replacement as its population ages and degenerative joint conditions become more prevalent. Healthcare infrastructure is expanding beyond major metropolitan hospitals into regional centers. Domestic and international manufacturers are increasing access to advanced orthopedic implants. Greater awareness of joint replacement is also encouraging patients to seek surgical treatment earlier.

India Hip Replacement Market Trends

India is expected to emerge as a significant market, accounting for approximately 22% share in 2026, due to aging, osteoarthritis, trauma cases, and improving access to orthopedic care. Private hospitals and specialized orthopedic centers are expanding advanced joint replacement services. Robotic assistance, improved implant designs, and minimally invasive approaches are gaining clinical interest. Stryker’s launch of the Trident II Acetabular System in India in April 2026 demonstrates continued expansion of advanced hip replacement technologies in the country.

The global hip replacement market exhibits a moderately fragmented structure, driven by the presence of established orthopedic device manufacturers, continuous implant innovation, and increasing adoption of robotic-assisted and minimally invasive procedures. With key leaders including Stryker, Zimmer Biomet, Johnson & Johnson MedTech, Smith+Nephew, and Medtronic, competition remains focused on expanding comprehensive hip implant portfolios and improving clinical outcomes.

These players compete through product innovation, advanced bearing materials, improved fixation technologies, patient-specific planning, and strategic expansion across emerging markets. Companies are increasingly integrating additive manufacturing, dual-mobility systems, digital planning, and robotic assistance to improve implant positioning and procedural efficiency.

Key Industry Developments:

• In April 2026, Stryker launched the Trident II Acetabular System in India, an advanced solution for total hip arthroplasty designed to provide greater precision, improved stability, and increased confidence during hip replacement procedures.
• In June 2026, DePuy Synthes launched VELYS™ Hip Navigation with AI Assistance in the U.S., introducing AI-powered image interpretation and landmark identification to support patient-specific insights and improve consistency and efficiency during total hip arthroplasty.